No Data
Citi Research's U.S. Equity Strategy Large-Cap Recommendation List
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Price Over Earnings Overview: Johnson & Johnson
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
Pyxis Oncology Plummets 38% on Preliminary Phase 1 Data for Cancer Asset
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate